EVALUATION OF PRESCRIBED CARDIOVASCULAR DRUGS MARKETED BY VARIOUS PHARMACEUTICAL COMPANIES OF BANGLADESH

Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2013, Vol 2, Issue 3

Abstract

Cardiovascular drugs encompass a large number of prescription medications that are used to control heart disease. It is a complicated group of drugs with many being used for multiple heart conditions. The main objective of this survey was to analyze the prescribed cardiovascular drugs with their brand name marketed by different local and international companies of Bangladesh. This was a descriptive cross-sectional survey involving patients, physicians and pharmacy in-charge based on a structured questionnaire format with answer sets and followed up by prescription monitoring. This study carried out at the outdoor of National Heart Foundation (Mirpur, Dhaka) and the Dhaka medical college hospital Pharmacy (Dhaka, Bangladesh) from January’12 to August’12. From total 700 prescriptions, 99% prescriptions were prescribed by the specialist but only 1% by general physicians. Out of the total patients with a male, female ratio of 57.14: 42.86, all patients were over 30 years and approximately 64.285 % the patients were demographically from urban area whereas 35.714% patients came from rural area. Individual patients got different classes of drugs including Beta-blockers, Organic nitrates, anticoagulant, antiplatelet and thrombolytic agents, Calcium channel blockers, Diuretics, ACE inhibitors, Lipid lowering agents and Miscellaneous agents were respectively 25.00, 19.57, 22.00,8.42,10.42,10.40 and 2.85 percent. This study may be guidelines for optimizing rational use of cardiovascular drugs and also a new statistical approach for effective cardiovascular disease management in Bangladesh.

Authors and Affiliations

Zubair Khalid Labu| Department of Pharmacy, World University of Bangladesh, Dhaka 1205, Bangladesh,, Razia Sultana| Department of Pharmacy, World University of Bangladesh, Dhaka 1205, Bangladesh,, Samiul Basir| Department of Pharmacy, World University of Bangladesh, Dhaka 1205, Bangladesh,, Jalal Uddin| Department of Pharmacy, World University of Bangladesh, Dhaka 1205, Bangladesh,, Afsana Afrin| Department of Pharmacy, World University of Bangladesh, Dhaka 1205, Bangladesh,, Nadia Sultana| Department of Pharmacy, World University of Bangladesh, Dhaka 1205, Bangladesh,

Keywords

Related Articles

Fluconazole susceptibility of Candida species isolated from cases of Vulvovaginal Candidiasis by using E-test method

Candida vaginitis is one of the most frequently encountered forms of superficial candidiasis. The principal agent of vulvovaginal candidiasis is C.albicans, but other species known generally as C.nonalbicans (C.glabrata,...

PHAGE THERAPY: THE USE OF BACTERIOPHAGES AGAINST INFECTIONS

Phages are a kingdom of viruses that infect bacteria, and are distinct from the animal and plant viruses. Phages can have either a “lytic” or a “lysogenic” life cycle. After their discovery early in the 20th century, pha...

Bedaquiline: A Novel Addition to Anti-Tubercular Armamentarium

In current scenario of rising trend of resistant tuberculosis (TB) and acquired immunodeficiency syndrome (AIDS) co infection with TB, a novel antitubercular drug is a prime need to effectively decrease the disease burde...

ASSESSMENT OF QTC INTERVAL: A CARDIOVASCULAR RISK FACTOR IN ASYMPTOMATIC TYPEII DIABETICS

Background and Objectives: Diabetes Mellitus (DM), metabolic disorder, characterized by hyperglycaemia. There are two main types of diabetes mellitus. Insulin dependent diabetes mellitus (type I DM), Non insulin depende...

Download PDF file
  • EP ID EP1799
  • DOI -
  • Views 461
  • Downloads 26

How To Cite

Zubair Khalid Labu, Razia Sultana, Samiul Basir, Jalal Uddin, Afsana Afrin, Nadia Sultana (2013). EVALUATION OF PRESCRIBED CARDIOVASCULAR DRUGS MARKETED BY VARIOUS PHARMACEUTICAL COMPANIES OF BANGLADESH. Journal of Biomedical and Pharmaceutical Research, 2(3), 77-84. https://www.europub.co.uk/articles/-A-1799